Blu – Pagina 54 – AMD

Blu

Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.

Febbraio 22, 2024 dario.olivero

Lifetime duration of breastfeeding and cardiovascular risk in women with type 2 diabetes or a history of gestational diabetes: Findings from two large prospective cohorts

Birukov A, Guasch-Ferré M, H. Ley S, et al.
Diabetes Care. 2024;dc231494.

Leggi

Febbraio 19, 2024 dario.olivero

The impact of stigma on the management of type 1 diabetes: A systematic review

Embick R, Jackson M, Stewart R
Diabet Med. 2024:e15299.

Leggi

Febbraio 19, 2024 dario.olivero

Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study

Kim KS, Hong S, Han K, Park CY
BMJ. 2024;384:e076388.

Leggi

Febbraio 19, 2024 dario.olivero

Association between pregnancy-related complications and development of type 2 diabetes and hypertension in women: an umbrella review

Wambua S, Singh M, Okoth K, et al.
BMC Med. 2024;22(1):66.

Leggi

Febbraio 19, 2024 dario.olivero

Effects of ADHD and ADHD treatment on glycemic management in Type 1 diabetes: A systematic review and meta-analysis of observational studies

Zare Dehnavi A, Elmitwalli I, Alsharif HOH, et al.
Diabetes Res Clin Pract. 2024:111566.

Leggi

Febbraio 19, 2024 dario.olivero

Exploration of the potential association between GLP-1 receptor agonists and suicidal or self-injurious behaviors: a pharmacovigilance study based on the FDA Adverse Event Reporting System database

Zhou J, Zheng Y, Xu B, et al.
BMC Med. 2024;22(1):65.

Leggi

Febbraio 19, 2024 dario.olivero

Nutritional interventions for preventing and treating pressure ulcers

Langer G, Wan CS, Fink A, et al.
Cochrane Database Syst Rev. 2024;2(2):CD003216.

Leggi

Febbraio 15, 2024 dario.olivero

Denosumab and the risk of diabetes in patients treated for osteoporosis

HuangHK, Chuang ATM, Liao TC, et al.
JAMA Netw Open. 2024;7(2):e2354734.

Leggi

Febbraio 15, 2024 dario.olivero

IDegLira for the real‐world treatment of type 2 diabetes in Italy. Final results from the REX observational study

Fadini GP, Buzzetti R, Pitocco D, et al.
Diabetes Obes Metab. Pub. online 8 Feb 2024.

Leggi

Febbraio 15, 2024 dario.olivero

Estimated lifetime cardiovascular, kidney, and mortality benefits of combination treatment with SGLT2 inhibitors, GLP-1 receptor agonists, and nonsteroidal mra compared with conventional care in patients with type 2 diabetes and albuminuria

Neuen BL, Heerspink HJL, Vart P, et al.
Circulation. 2024;149(6):450-462.

Leggi